Hillsdale Investment Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-35,200	Closed	-$160K	–	487
2017 Q1	$160K	Buy	+35,200	New	+$160K	0.03%	282